Target Name: SNX30
NCBI ID: G401548
Other Name(s): Sorting nexin 30 | Sorting nexin-30 | FLJ34280 | sorting nexin family member 30 | FLJ26481 | FLJ44686 | FLJ35589 | OTTHUMP00000021943 | SNX30_HUMAN | Sorting nexin family member 30 | FLJ45069 | FLJ46877 | ATG24A

SNX30: A Potential Drug Target and Biomarker for Mental Health

Sorting Nexin 30 (SNX30) is a protein that is expressed in the brain and is involved in the regulation of emotional behavior, anxiety, and depression. It is a small non-coding RNA molecule that plays a crucial role in neural development, function, and behavior. The discovery of SNX30 as a potential drug target and biomarker for mental health has significant implications for the treatment of psychiatric disorders.

An Overview of SNX30

SNX30 is a non-coding RNA molecule that is expressed in the brain and is involved in the regulation of emotional behavior, anxiety, and depression. It is a small molecule that consists of only 18 amino acid residues. SNX30 is expressed in various tissues of the brain, including the prefrontal cortex, amygdala, hippocampus, and striatum. It is involved in the regulation of neural circuitry and is thought to play a role in the development and maintenance of emotional and behavioral behaviors.

The Discovery of SNX30

SNX30 was first identified as a new gene in the mouse database using a technique called transcriptome sequencing. The gene was named based on its ability to sorted expression in the brain. SNX30 is a small non-coding RNA molecule that is expressed in the brain and is involved in the regulation of emotional behavior, anxiety, and depression.

SNX30 is a critical molecule in the regulation of neural circuitry. It is expressed in the prefrontal cortex, amygdala, hippocampus, and striatum and is involved in the regulation of neural circuitry. Studies have shown that SNX30 is involved in the regulation of neural circuitry and that it plays a role in the development and maintenance of emotional and behavioral behaviors.

Potential Drug Target

SNX30 is a potential drug target for the treatment of psychiatric disorders. Studies have shown that SNX30 is involved in the regulation of neural circuitry and that it plays a role in the development and maintenance of emotional and behavioral behaviors. This makes SNX30 an attractive drug target for the treatment of psychiatric disorders such as depression, anxiety, and schizophrenia.

SNX30 has been shown to play a role in the regulation of neural circuitry in the brain. Studies have shown that SNX30 is involved in the regulation of the strength of neural circuits in the brain and that it plays a role in the development and maintenance of emotional and behavioral behaviors. This suggests that SNX30 may be a useful biomarker for the treatment of psychiatric disorders.

Biomarker

SNX30 has also been shown to be a potential biomarker for the treatment of psychiatric disorders. Studies have shown that SNX30 is significantly reduced in the brains of individuals with depression, anxiety, and schizophrenia. This suggests that SNX30 may be a useful biomarker for the diagnosis and treatment of psychiatric disorders.

Conclusion

SNX30 is a small non-coding RNA molecule that is expressed in the brain and is involved in the regulation of emotional behavior, anxiety, and depression. The discovery of SNX30 as a potential drug target and biomarker for mental health has significant implications for the treatment of psychiatric disorders. Further research is needed to fully understand the role of SNX30 in neural development, function, and behavior.

Protein Name: Sorting Nexin Family Member 30

Functions: Involved in the regulation of endocytosis and in several stages of intracellular trafficking (PubMed:32513819). Together with SNX4, involved in autophagosome assembly (PubMed:32513819)

More Common Targets

SNX31 | SNX32 | SNX33 | SNX4 | SNX5 | SNX6 | SNX7 | SNX8 | SNX9 | SOAT1 | SOAT2 | SOBP | SOCAR | SOCS1 | SOCS2 | SOCS2-AS1 | SOCS3 | SOCS3-DT | SOCS4 | SOCS5 | SOCS5P5 | SOCS6 | SOCS7 | SOD1 | SOD2 | SOD2-OT1 | SOD3 | Sodium channel | Sodium-Glucose Cotransporter (SGLT) | Sodium-potassium-calcium exchanger | SOGA1 | SOGA3 | SOHLH1 | SOHLH2 | Soluble (cytosolic) protein tyrosine phosphatases | Soluble guanylyl cyclase | Solute Carrier Family 12 | Solute carrier family 29 member | Somatostatin receptor | SON | SORBS1 | SORBS2 | SORBS3 | SORCS1 | SORCS2 | SORCS3 | SORCS3-AS1 | SORD | SORD2P | SORL1 | SORT1 | Sorting and assembly machinery complex | Sorting nexin | SOS1 | SOS2 | SOSS complex | SOST | SOSTDC1 | SOWAHA | SOWAHB | SOWAHC | SOWAHD | SOX1 | SOX1-OT | SOX10 | SOX11 | SOX12 | SOX13 | SOX14 | SOX15 | SOX17 | SOX18 | SOX2 | SOX2-OT | SOX21 | SOX21-AS1 | SOX3 | SOX30 | SOX30P1 | SOX4 | SOX5 | SOX5-AS1 | SOX6 | SOX7 | SOX8 | SOX9 | SOX9-AS1 | SP1 | SP100 | SP110 | SP140 | SP140L | SP2 | SP2-AS1 | SP3 | SP3P | SP4 | SP5 | SP6 | SP7